Support for Individual Accounts
SYSTEM STATUS
Getting Started:
Visit our Welcome Center for info on trading, managing, funding, and configuring your account, plus other key features.
Find Answers Fast
Investor Grievance Escalation Matrix for IB India Accounts
Please contact our Client Services Team directly through our secure Client Portal for any assistance matters. In the event that you do not receive a timely response or are not satisfied with the response provided, you can send an email with your case details (ticket number; chat/call summary), as per the below escalation matrix. Please do not use the escalation matrix as the first line of communication. Escalation emails sent without the details of a previous case history (ticket number; chat/call summary) may not be further processed.
| Details of | Contact Person | Address | Contact Number | Email Address |
|---|---|---|---|---|
| Customer Care | Rinku Chauhan | 502/A, Times Square, Andheri Kurla Road, Andheri East, Mumbai 400059, India | +91-22-61289888 (Mon-Fri ; 10 am to 5 pm) |
customercareescalation.in@interactivebrokers.com |
| Head of Customer Care/Board Member | Praveen Kamath | +91-22-39696188 (Mon-Fri ; 10 am to 5 pm) |
customercareheadescalation.in@interactivebrokers.com | |
| Compliance Officer | Bina Shah | +91-22-61289825 (Mon-Fri ; 10 am to 5 pm) |
complianceofficerescalation.in@interactivebrokers.com |
Should you require additional support after contacting Client Services, you may submit a complaint or dispute to the following:
- Exchange: https://investorhelpline.nseindia.com/NICEPLUS/
- NSDL: https://www.epass.nsdl.com/complaints/websitecomplaints.aspx
- SEBI: https://scores.sebi.gov.in
Additionally, you can raise a complaint or dispute via the Online Dispute Resolution (ODR) portal http://smartodr.in. Please include your Service Ticket/Complaint Ref No. while raising your complaint at Exchange/Depository/SEBI SCORES/ODR Portal.
The NSE cautions and advises investors not to subscribe to any prohibited scheme or products. Participation in such prohibited schemes is at the investors' own risk, as such schemes are neither approved nor endorsed by the Exchange. Further details on the NSE Press releases can be found on their website here.